Key result
The ADAMPA trial is a planned pragmatic randomized controlled trial designed to evaluate whether self-monitoring of blood pressure and self-titration of medication reduces systolic blood pressure compared to usual care.
Why the study?
Does self-management with home blood pressure monitoring and self-titration of medication decrease systolic blood pressure compared to usual care in patients with poorly controlled hypertension?
RCT (n=458)
Unblinded
1:1 ratio using a computer randomization system via internet with minimization
Yes
Does self-management with home blood pressure monitoring and self-titration of medication decrease systolic blood pressure compared to usual care in patients with poorly controlled hypertension?
Answers are grounded in this paper and cite their sources.
This study protocol outlines a pragmatic trial to evaluate whether self-monitoring and self-titration of antihypertensive medication can improve blood pressure control in primary care.
BACKGROUND: Lack of control of hypertension is one of the most prevalent problems encountered by general practitioners (GPs). Self-measured blood pressure monitoring at home (SMBP) and self-titration of medication could be a good strategy to improve hypertension management, however, evidence is limited and not conclusive. We aimed to assess the effectiveness, in the primary care setting, of an intervention that includes educational components, SMBP and self-titration of antihypertensive medication to decrease systolic blood pressure compared to usual care, in a population with poorly controlled hypertension, during a 12-month period. METHODS: Pragmatic, controlled, randomized, unblinded clinical trial with two parallel groups assigned in a ratio of 1:1 to self-management (which includes educational components, SBMP and self-titration of antihypertensive medication based on a patient's GP's pre-established adjustment plan) or to usual care (with educational components too). DISCUSSION: If the data from this trial show positive results, the study may contribute to a change of strategy in the treatment of hypertension, focusing on the patient as the main actor to achieve blood pressure control. Furthermore, this approach might contribute to the financial sustainability of the National Health Service. TRIAL REGISTRATION: This trial has been registered in the database with reference number EudraCT: 2016-003986-25. Registered 05 May 2017, https://www.clinicaltrialsregister.eu/ctr-search/search?query=2016-003986-25.
No takes yet. Share an insight, caveat, or question.
Sanfélix‐Genovés et al. (2018) conducted an RCT in Poorly controlled hypertension (n=458). Self-monitoring blood pressure at home (SMBP) and self-titration of antihypertensive medication vs. Usual care was evaluated on Change in mean systolic blood pressure (SBP) between baseline and 12 months. The ADAMPA trial is a planned pragmatic randomized controlled trial designed to evaluate whether self-monitoring of blood pressure and self-titration of medication reduces systolic blood pressure compared to usual care.
Synapse has enriched 10 related papers. Consider them for comparative context: